Breath-synchronized mesh nebulization has been shown to significantly outperform continuous output in both deposition and absorption. Studies report that, under certain conditions, the respirable dose with breath-sensing mode can be 1.7 to 3.6 times higher than traditional continuous nebulization. Furthermore, antibiotic concentrations in sputum samples have reached levels 4 to 7 times greater—highlighting the efficiency of this targeted delivery approach.

Air360® technology reduces unnecessary airway pressure by avoiding aerosol delivery during exhalation, minimizing patient discomfort and breathing resistance. For critically ill patients who require continuous ventilatory support and medication, this approach offers both therapeutic precision and improved tolerance. By aligning therapy with natural breathing patterns, AirICU supports safer, more comfortable respiratory care—even in the most complex ICU environments.

Whether treating adults or children, conscious or mechanically ventilated patients, Air360® technology adapts with precision. Its breath-sensing algorithm ensures seamless synchronization without the need for external triggers or manual adjustments. This enables consistent, reproducible drug delivery during spontaneous, assisted, or fully controlled ventilation scenarios.